11 results
Pacemaker Coding Terminology
#Diagnosis #Cardiology #PPM #Pacemaker #LetterCode #Coding #Classification #Table #CoreEM
Pacemaker Coding ... PPM #Pacemaker #LetterCode ... #Coding #Classification ... #Table #CoreEM
The first three letters refer to chamber paced, chamber sensed, and response to sensed events. The
PPM #Pacemaker #LetterCode ... #Coding #Classification ... #Table
Pharmacologic prophylaxis of VTE in selected clinical scenarios.

Enoxaparin 
Dalteparin 
Fondaparinux 
Dabigatran 
Unfractionated Heparin
Warfarin 
Aspirin 

#prophylaxis #VTE
VTE in selected clinical ... prophylaxis #VTE #DVT #dosing ... #Medications #management ... #indications #pharmacology ... #table
Classification, Differential Diagnosis, and Features of Hyponatremia According to Volume Status 

Hypervolemic hypernatremia 
 - CHF
Classification, ... deficit - Salt-losing ... #Hyponatremia #Classification ... Differential #Diagnosis #Table
Managing warfarin INR

Warfarin dosage must be individualized according to the patient's response to the drug, and
For most indications ... #management #algorithm ... pharmacology #treatment #medications ... #table #pharmacotherapy ... hematology #warfarin #dosing
Forrest Classification for Peptic Ulcer Bleeding
Rebleeding risks are without endoscopic intervention
1a - Spurting Bleed - 60-100%
Forrest Classification ... Re-bleeding Ib - Oozing ... Re-bleeding #Forrest #Classification ... gastroenterology #EGD #clinical
Complex Perianal Fistulas and Crohn's Disease - Management Algorithm
Factors for Operative Strategy
  • Fistula Classification
Disease - Management Algorithm ... Strategy • Fistula Classification ... response to standard dosing ... perianal disease Algorithm ... #Disease #IBD #algorithm
Daliresp (Roflumilast) 
Indication: Reduce risk of COPD exacerbations 
Drug Class: Selective Phosphodiesterase-4 (PDE4) Inhibitor 
GOLD 2019
Eosinophils < 100 Dosing ... : 250 mcg tablet ... the use of this medication ... won’t have any clinical ... #Roflumilast #Indications
SLE (Systemic Lupus Erythematosus)

Suspect:
Clinical evidence of (fatigue, rash, photosensitivity, inflammatory arthritis, weight loss, and fever) and
) Suspect: Clinical ... Skin Disease Classification ... lymphoproliferative syndrome Clinical ... pancreatitis, protein-losing ... activation and/or medications
IDSA Recommendations for Treating Mycobacterium Tuberculosis Infection and Disease in HIV-AIDS
Treating LTBI (to prevent TB disease)
Indications:
prevent TB disease) Indications ... HIV-infected persons with clinical ... Please refer to the table ... below for TB drug dosing ... Guidelines for dosing